Raccoon tests positve for rabies in Chapel Hill - WRAL
A file photo of a rabies pamphlet on how to protect yourself. By WRAL Staff const body = document.getElementsByClassName("article-body"), smallFontButton = document.getElementById("small-font-button"), mediumFontButton = document.getElementById("medium-font-button"), largeFontButton = document.getElementById("large-font-button"); smallFontButton.addEventListener("click", t => { body.classList.add("small-font"), body.classList.remove("medium-font"), body.classList.remove("large-font") }), mediumFontButton.addEventListener("click", t => { body.classList.remove("small-font"), body.classList.add("medium-font"), body.classList.remove("large-font") }), largeFontButton.addEventListener("click", t => { body.classList.remove("small-font"), body.classList.remove("medium-font"), body.classList.add("large-font") }) Orange County Animal Services said a raccoon tested positive for rabies.
Ebola, chemical plants and health, hantavirus, common colds, heat and more - Your Local Epidemiologist
Katelyn JetelinaMay 27, 20264144366ShareAs they say, bugs have ears. Public health has had a relentless May.
Scientists create supercharged vitamin K that helps the brain heal itself - ScienceDaily
Diseases such as Alzheimer's, Parkinson's, and Huntington's slowly damage the brain by destroying neurons, the cells that carry messages through the nervous system. As these cells are lost, people can experience memory problems, cognitive decline, and movement difficulties that often become severe enough to require constant care.
The Remarkable Proliferation of Cancer Immunotherapies - Ground Truths | Eric Topol
220948ShareIt has been 15 years since the first unequivocal proof that an immune checkpoint inhibitor (anti-CTLA-4, the T cell receptor shown in blue below; pink represents the antibody) was shown to extend survival in patients with metastatic melanoma and received FDA approval. The 2013 Breakthrough of the Year for Science Magazine was cancer immunotherapy, recognizing unleashing the brakes of T cells for some remarkably improved outcomes for patients with a variety of refractory cancers.